The global topical pain relief market was valued at $8,864.0 million in 2019, and is projected to reach $12,219.7 million by 2027 at a CAGR of 5.2% from 2020 to 2027. Increase in prevalence of ...

Unlike existing treatments-such as NSAIDs, lidocaine patches, capsaicin creams, and systemic painkillers-topical Ketamir-2 aims to provide effective, long-lasting relief without the risks of ...

These topical drugs can help provide pain relief ... Nonsteroidal anti-inflammatory drugs or NSAIDs are available both over the counter and by prescription. Almost everyone with arthritis has ...

Ketamir-2's topical treatment has the potential to overcome these issues by delivering localized pain relief without the systemic side effects seen with oral medications. This could represent a ...